The downfall is just because of scared investors, (rightly so some might say).
- Satipharm sales equaled a mere 5,000 Canadian dollars in Q4 2017. Germany and Ireland failed to recognise the product as a "food supplement."
- The existing markets are already saturated with licensed producers (in better positions, again some will say).
- Our brand awareness as be average to say the least, regarding to Royal High and Captains Choice.
- We need to build better clinic relationships.
- We paid an inflated price for Dreamwater, due to its explosive growth, HvstOne has little experience running a CPG company, and Canopy has teamed up with Constellation brands (STZ) to develop a similar product.
Cut short an article about Hvst One, full link below
https://seekingalpha.com/article/4178611-harvest-one-cannabis-cautious-outlook-due-execution-risk
Harvest One Share Price, page-1671
-
- There are more pages in this discussion • 1,025 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add HGV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.2¢ |
Change
-0.002(3.70%) |
Mkt cap ! $10.93M | |||
| Open | High | Low | Value | Volume |
| 5.4¢ | 5.4¢ | 5.2¢ | $13.31K | 250.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 133097 | 5.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.4¢ | 322989 | 1 |
View Market Depth
| Last trade - 12.43pm 01/11/2024 (20 minute delay) ? |
| HGV (ASX) Chart |